Erratum to: Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications.
All Authors:
Authors
Kesselheim AS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Seeger JD, Brownstein JS, Woloshin S, Schwartz LM, Toomey T, Dal Pan GJ, Avorn J.
Author Profiles:
Persons
Publish Date:
Date
Journal:
Venue / Journal
Drug Saf
Additional Journal Information
38(9):845